Results 21 to 30 of about 653 (163)

Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration

open access: yesJournal of Ginseng Research, 2016
Background: A number of neurological and neurodegenerative diseases share impaired cognition as a common symptom. Therefore, the development of clinically applicable therapies to enhance cognition has yielded significant interest.
Sungmin Kim   +7 more
doaj   +3 more sources

Neurolipid systems: A new target for the treatment of dementia [PDF]

open access: yesBasic &Clinical Pharmacology &Toxicology, Volume 135, Issue 3, Page 225-236, September 2024.
Neurolipids comprise a diverse class of bioactive lipids that include molecules capable of activating G protein-coupled receptors, thereby inducing systemic effects that contribute to the maintenance of homeostasis.
Bengoetxea de Tena, Iker   +6 more
core   +2 more sources

Effects of gintonin-enriched fraction on hippocampal gene expressions

open access: yesIntegrative Medicine Research, 2021
Background: Recently, gintonin and gintonin-enriched fraction (GEF) have been isolated from ginseng, a herbal medicine. Gintonin induces [Ca2+]i transition in cultured hippocampal neurons and stimulates acetylcholine release through LPA receptor ...
Rami Lee   +8 more
doaj   +3 more sources

Gintonin Isolated from Ginseng Inhibits the Epithelial—Mesenchymal Transition Induced by TGF-β in A549 Lung Cancer Cells [PDF]

open access: yesPlants, 2023
Epithelial-to-mesenchymal transition (EM transition) is a process wherein epithelial cells lose their intrinsic characteristics and cell–cell junctions and differentiate into a mesenchymal phenotype.
Sung Jin Kim   +4 more
doaj   +2 more sources

Cognitive function improvement effects of gintonin-enriched fraction in subjective memory impairment: An assessor- and participant-blinded placebo-controlled study [PDF]

open access: yesJournal of Ginseng Research, 2023
Background: Gintonin is a new material of ginseng that acts through the ginseng-derived lysophosphatidic acid (LPA) receptor ligand. The gintonin-enriched fraction (GEF) inhibits amyloid plaque accumulation in the cortex and hippocampus, improves ...
Rami Lee   +4 more
doaj   +2 more sources

Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor

open access: yesJournal of Ginseng Research, 2021
Background: We recently showed that gintonin, an active ginseng ingredient, exhibits antibrain neurodegenerative disease effects including multiple target mechanisms such as antioxidative stress and antiinflammation via the lysophosphatidic acid (LPA ...
Sung Min Nam, Sun-Hye Choi, Hee-Jung Cho
exaly   +3 more sources

Gintonin-Enriched Fraction Suppresses Heat Stress-Induced Inflammation through LPA Receptor [PDF]

open access: yesMolecules, 2020
Heat stress can be caused by various environmental factors. When exposed to heat stress, oxidative stress and inflammatory reaction occur due to an increase of reactive oxygen species (ROS) in the body.
Sungwoo Chei   +7 more
doaj   +3 more sources

Ginseng Nanosizing: The Second Spring of Ginseng Therapeutic Applications [PDF]

open access: yesAntioxidants
Plant-derived vesicles offer several advantages, including high yield, low cost, ethical compatibility, safety, and potential health benefits. These advantages enable them to overcome technological limitations associated with vesicles of mammalian origin.
Jian Wang   +8 more
doaj   +2 more sources

Amelioration of muscle wasting by gintonin in cancer cachexia

open access: yesNeoplasia: An International Journal for Oncology Research, 2021
Cancer cachexia is characterized by systemic inflammation, protein degradation, and loss of skeletal muscle. Despite extensive efforts to develop therapeutics, only few effective treatments are available to protect against cancer cachexia. Here, we found
Yoseph Toni Wijaya   +4 more
doaj   +3 more sources

Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors

open access: yesFrontiers in Pharmacology, 2018
Gintonin is a ginseng-derived lysophosphatidic acid receptor (LPAR) ligand. Although previous in vitro and in vivo studies demonstrated the therapeutic role of gintonin against Alzheimer’s disease, the neuroprotective effects of gintonin in Parkinson’s ...
Seikwan Oh, Seung-Yeol Nah, Ik-Hyun Cho
exaly   +3 more sources

Home - About - Disclaimer - Privacy